ClinicalTrials.gov record
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
COMPLETED · NCT00680225
Trial record
NCT IDNCT00680225
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
10
Conditions
Choroidal Melanoma
Interventions
Ranibizumab injection and TTT - ICG based
Locations
New England Retina Associates, Hamden, Connecticut, United States
Indexed topics
Last update
2017-04-10